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Abstract Attention problems form one of the core
characteristics of Attention-Deficit Hyperactive Disorder
(ADHD), a multifactorial neurodevelopmental disorder.
From twin research it is clear that genes play a considerable
role in the etiology and in the stability of ADHD in child-
hood. Association studies have focused on genes involved in
the dopaminergic and serotoninergic systems, but with
inconclusive results. This study investigated the effect of 26
Single Nucleotide Polymorphisms (SNPs) in genes encoding
for serotonin receptors 2A (HTR2A), Catechol-O-Methyl-
transferase (COMT), Tryptophane Hydroxylase type 2
(TPH2), and Brain Derived Neurotrophic Factor (BDNF).
Attention problems (AP) were assessed by parental report at
ages 3, 7, 10, and 12 years in more than 16,000 twin pairs.
There were 1148 genotyped children with AP data. We
developed a longitudinal framework to test the genetic
association effect. Based on all phenotypic data, a longitu-
dinal model was formulated with one latent factor loading on
all AP measures over time. The broad heritability for the AP
latent factor was 82%, and the latent factor explained around
55% of the total phenotypic variance. The association of
SNPs with AP was then modeled at the level of this factor.
None of the SNPs showed a significant association with AP.
The lowest p-value was found for the rs6265 SNP in the
BDNF gene (p = 0.035). Overall, our results suggest no
evidence for a role of these genes in childhood AP.
Keywords Attention problems  Genetics 
Candidate genes
Introduction
Attention-Deficit Hyperactivity Disorder (ADHD) is a
neurodevelopmental disorder starting early in childhood.
Core characteristics are attention deficits, hyperactivity and
impulsivity. Twin, family and adoption studies suggest that
ADHD is one of the most heritable psychiatric disorders.
A mean estimate of the heritability of ADHD is 76% both
in children and adults (Biederman and Faraone 2005;
Faraone et al. 2005; Derks et al. 2009).
Many candidate association studies for ADHD have
been conducted. Candidate gene studies with a focus on the
dopaminergic system showed most consistent results, but
the genes accounted only for a small part to the genetic
variation of ADHD. Candidate genes involving into the
serotonergic and noradrenergic systems are also widely
investigated, but their contribution in the etiology of
ADHD is not conclusive (for reviews see: Banaschewski
et al. 2010; Gizer et al. 2009; Franke et al. 2009). One of
the reasons for the lack of success of candidate genes
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studies, may be the heterogeneity and complexity of
ADHD (Hudziak 2001; Steinhausen 2009). Furthermore, it
is likely that a large number of different genes are impli-
cated in the etiology of ADHD, each with a small genetic
effect. Most studies lacked the power to detect the small
effects of these genes (Bergen et al. 2010). Therefore
genetic association studies need strategies that help to
increase the statistical power (Faraone et al. 2005; Neale
et al. 2008).
One strategy to increase power is by using a longitudinal
design (Hottenga and Boomsma 2007). Such design may be
especially useful for stable characteristics for which the same
genes are implicated. Recently, Middeldorp et al. (2010)
developed a longitudinal design for genetic association
analyses on depression and anxiety. The effect of SNPs was
tested on a latent factor expressing the shared variance across
time points spanning more than 10 years. The heritability
estimate for the anxiety/depression latent factor was higher
than the heritability estimates for the anxiety/depression
measures at each age separately. As such, more power to
detect associations is achieved (Medland and Neale 2010;
Minica et al. 2010). A power analysis revealed that by
applying this longitudinal approach it is possible to detect
effects explaining 1.4% to 3.6% of the variance with a power
of 80%. This was considerably higher than for univariate
models tested in samples of equal size.
In the present study we test the association between
genes and Attention Problems (AP). Attention Problems
were measured with the Child Behavior Checklist (CBCL)
(Achenbach 1991, 1992) and used as index for ADHD.
Derks et al. (2008) showed that the genetic overlap
between the CBCL AP scale and the DSM-IV diagnosis of
ADHD is high. They reported genetic correlations ranging
between 0.52 and 0.68.
The choice of the candidates genes was based on the
availability of a genotype dataset consisting of single
nucleotide polymorphisms (SNPs) from a study of
Middeldorp et al. (2010). From this set we selected candi-
date genes with a possible impact on the etiology of AP as
reported in the literature (Banaschewski et al. 2010; Gizer
et al. 2009; Franke et al. 2009). SNPs were available for
genes involved in coding of the 2A serotonin receptor
(HTR2A), tryptophane hydroxylase (TPH2), Catechol-
O-Methultransferase (COMT), and neurogenenis: Brain
Derived Neurotrophic Factor (BDNF). HTR2A and TPH2
are were involved in the serotoninergic system, which is
mentioned as possible pathway in the etiology of ADHD
because of its relation with impulsive-aggressive behaviors
in children (Gizer et al. 2009; Halperin et al. 1997). There is
evidence that HTR2A has a moderating role on dopamine
activity and hyperlocomotion after amphetamine adminis-
tration (O’Neill et al. 1999). Also TPH2 may play a role in
dopamine activity, since it is involved in the production of
serotonin (Walther et al. 2003). One SNP was available for
COMT, a gene involved in the regulation of synaptic
dopamine in the frontal cortex. Since both frontal cortical
dysfunction and abnormalities in the dopaminergic system
have been related to ADHD (Genro et al. 2010), the COMT
gene may be a good candidate. SNPs for BDNF were
included because of its role in neuronal plasticity and
neurogenesis (Tsai 2007). Evidence for a role of BDNF
came from pharmacological studies, were it was found that
commonly used drugs for ADHD treatment modulate the
expression of BDNF (Meredith et al. 2002). In addition,
heterozygous BDNF knockout mice display symptoms
related to ADHD (Linnarsson et al. 1997).
To test for the genetic associations we apply the longi-
tudinal method as developed by Middeldorp et al. (2010).
In a cohort of over 16,000 twin pairs, we first modeled
longitudinal data collected at ages 3, 7, 10 and 12 year,
with a latent factor model to explain the covariance
between measures at all ages. In a subsample of 1148
children with genotype data, the effect of the SNPs on AP
was tested. To make use of all available data, the effect of
the SNPs was modeled on the common latent factor.
Methods
Participants
The study is part of an ongoing longitudinal twin study in
the Netherlands. The twins were registered with the
Netherlands Twin Registry (NTR) shortly after birth by
their parents (Bartels et al. 2007; Boomsma et al. 2006).
During the first 12 years of their lives the parents received
surveys with items on behavioral and emotional develop-
ment about every 2 years. The present study included data
collected at ages 3, 7, 10 and 12 years. Reports by both
father and mother were included in the current study.
Random subsamples of the young twins were also
invited to participate in experimental and laboratory studies
(for example, the studies of genetics of cognition, attention
and brain function) and provide a DNA sample (Boomsma
et al. 2006). Genotyping data were obtained for 1,148
children from 593 families and included 569 boys and 579
girls who also had at least one AP score. As this sample
included 305 monozygotic male (MZM) twins (150 com-
plete pairs) and 343 monozygotic female (MZF) twins (169
complete pairs), there were 419 (569 - 150) unique male
and 410 (579 - 169) unique female genotypes.
Longitudinal modeling was done first in the total sample
consisting of twins from 16,169 families, who participated
at least once, including 2,436 MZM, 2,856 DZM, 2,742
MZF, 2,556 DZF, 2,576 and 5602 dizygotic opposite sex
(DOS) twin pairs.
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We tested whether the genotyped subsample differed
from the total sample regarding sex, clinical range, birth
country parents, and Social Economic Status (SES). With a
percentage of 50% boys in the total sample and with 49.6%
boys in the genotyped samples, the sex distribution did not
differ between the 2 samples (v(1)
2 = 0.076, p = 0.783). The
percentages of children falling within the clinical range
(calculated as T-score of CBCL AP C67) were 4% and 4.6%
(age 3), 5.4% and 4.4% (age 7), 5.0 and 3.8% (age 10), 5.7%
and 5.3% (age 12) for respectively the total and the geno-
typed sample. The percentages did not differ between the 2
samples (age 3: v(1)
2 = 1.02, p = 0.296; age 7: v(1)
2 = 2.201,
p = 0.138; age 10: v(1)
2 = 2.87, p = 0.09; age 12: v(1)
2 =
0.21, p = 0.649). In the total and the genotyped sample of
twins, the majority of parents were born in Netherlands (93.1
and 92.9%) or in a western country (3.2 and 2.9%). In the
other families (3.7 and 4.2%) at least one parent was born in a
non-western country. These percentages were not different
between the two samples (v(2)
2 = 0.632; p = 0.729). Infor-
mation about SES was obtained from surveys completed by
parents and categorized into 3 SES groups. For the total and
the genotyped sample the percentage were 22.4 and 21.6%
low SES, 45.1 and 41.9% middle SES and 32.3 and 36.4%
high SES. These percentages did not differ between the two
samples (v(2)
2 = 4.438, p = 0.109).
Measures
AP is measured with the CBCL, a standardized question-
naire for parents to report specific behavioral, emotional,
and social problems (Achenbach 1991, 1992). The ques-
tionnaire used at age 3 years consisted of 100 items (CBCL/
2-3) and the questionnaire used for the 7, 10 and 12-years-
old twins consist of 120 items (CBCL/4-18). Parents were
asked to rate the behavior that the child displayed currently
or in the past 2 months on a 3-point scale: 0 if the problem
item was not true, 1 if the item was somewhat or sometimes
true, and 2 if it was very true or often true. As measure for
AP at age 3 we used the Overactive scale, which is based on
factor analyses of data from several Dutch population
samples (Koot et al. 1997). The Overactive scale derived
from the CBCL/2-3 contains 5 items. The AP scale derived
from the CBCL/4-18 contains 11 items (Verhulst et al.
1996). The raw sum scores of the items of the Overactive
and AP scale were used in the analyses. In order to obtain a
distribution that approaches normality with respect to
skewness and kurtosis, normal scores were computed using
PRELIS (Jo¨reskog and So¨rbom 1986).
Genotyping
Table 1 shows the set with genotyped SNPs. The set of
SNPs was obtained from a previous study examining the
relation between these SNPs and anxiety/depression
(Middeldorp et al. 2010). In the present study, SNPs of the
HTR2A, COMT, TPH2, and BDNF genes were included.
Tagging SNPs, were selected for BDNF and TPH2 in order
to capture most of the variation in these genes. Tagging
SNPs for BDNF and TPH2, were selected from HapMap
Public Release #19, applying the efficient multimarker
method with r2 [ 0.8, and minor allele frequency (MAF)
[0.05 as implemented in the HapMap web browsers
(http://www.hapmap.org) (de Bakker et al. 2005). For the
genomic region of the BDNF gene, we captured 38 out of
53 (71%) alleles at r2 [ 0.8. For the TPH2 gene we cap-
tured 108 out of 148 (72%) alleles at r2 [ 0.8.
Multiplex genotyping assays were designed using the
Sequenom MassARRAY Assay Design software Version
3.1 and performed with MassARRAY iPLEX (Sequenom
Inc, San Diego, CA). Amplification reactions were based
Table 1 The genotyped SNPs per gene, minor allele frequency
(MAF), the results of the Hardy–Weinberg Equilibrium (HWE) test in
the total sample and the effect of the SNPs (b)
Genes SNPs MAF p-value
HWE
b
BDNF rs2049048 A\G 15.6 Ns 0.03
rs7103873 C\G 45.1 Ns 0.09
rs6265 T\C 22.4 Ns -0.14*
rs11030107 G\A 24.8 Ns -0.01
rs11030123 A\G 9.2 Ns 0.01
rs1491851 T\C 40.6 Ns 0.06
rs17309930 A\C 17.6 Ns -0.09
rs7124442 C\T 31.6 Ns -0.01
COMT rs4680 G\A 43.8 Ns -0.02
HTR2A rs6311 T\C 42.0 Ns -0.04
rs6314 A\G 8.6 Ns 0.07
rs6313 A\G 44.1 0.008 -0.05
TPH2 rs1007023 G\T 14.9 Ns 0.07
rs10748190 G\A 42.0 Ns -0.02
rs12231356 T\C 7.3 Ns -0.09
rs1352251 C\T 43.2 Ns -0.03
rs1473473 C\T 16.1 0.00005 0.06
rs2129575 T\G 25.4 Ns 0.001
rs2171363 A\G 44.4 Ns -0.04
rs3903502 T\C 41.7 Ns -0.02
rs4474484 A\G 36.9 Ns -0.01
rs4760820 G\C 41.6 Ns 0.06
rs7305115 A\G 44.2 Ns -0.04
rs10748185 A\G 48.7 Ns 0.04
rs17110489 C\T 26.5 Ns -0.04
rs7300641 T\G 17.7 Ns 0.04
Asterisks for b’s indicate to p-value \0.05
ns nonsignificant
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on the manufacturer’s instructions with a modified protocol
(Macgregor et al. 2008). Genotypes were assigned by using
Typer Analyzer version 4.0 software (Sequenom, San
Diego, CA). If there were disagreements or unclear posi-
tioned dots produced by Typer Analyzer 4.0 or more than
50% of the SNPs failed in a well, the SNPs were excluded
from analysis.
The set of SNPs was obtained from a dataset that
included two samples: one with children (twins) and one
with adult data (twins, parents, and sibs). Genotyping error
checks were performed in the dataset including both sam-
ples using Pedstats (see Middeldorp et al. 2010). If the
Mendelian inheritance was inconsistent, the individuals’
genotypes were set to unknown. After these corrections,
missingness per SNP was calculated. It appeared that
genotyping was successful in more than 98% of the sub-
jects for all SNPs with the exception of TPH2 rs1352251
(2.5% missing), COMT rs4680 (6.4% missing) and
HTR2A rs6311 (17.9% missing). For these three SNPs, we
checked whether the genotypes differed in a subsample of
subjects (N = 282) who were genotyped for the same
SNPs in another lab with an independent method (Sullivan
et al. 2009). Since this was not the case, we decided to
analyze these SNPs as well. Hardy–Weinberg Equilibrium
was tested in Haploview (Wigginton et al. 2005; Barrett
et al. 2005) resulting in 2 SNPs with a p-value below 0.01
(Table 1). These 2 SNPs were still included in the analyses
so that consistencies in results, for example more SNPs in
one gene showing a significant result, were not overlooked.
Statistical methods
Figure 1 shows the longitudinal model used to test the
effect of the SNPs on AP (Medland and Neale 2010;
Middeldorp et al. 2010). In the model one latent factor
(F, represented by a circle) influences on all observed AP
measures (represented by squares), explaining the shared
variance across ages and raters. From now on, we refer to
the latent factor as the AP factor. The variance of the AP
factor was constrained at 1. As AP measures within a twin
pair are not independent, the latent factors were correlated
between twins allowing different correlations for MZ and
DZ pairs. In Fig. 1, the arrow between the latent AP factors
reflects this twin correlation. In this figure, the latent fac-
tors e1 to e8 denote unique factors that account for the
residual variances of the observed variables. Genetic epi-
demiological analyses have shown that genetic factors are
not entirely the same over the ages 3–12 (Rietveld et al.
2003, 2004). To allow for age-dependent familial effects,
twin correlations were estimated for the unique factors.
These correlations also are allowed to differ for MZ and
DZ twin pairs. The factor loadings for the common and
Fig. 1 Factorial association model. The latent AP factor loads on the
longitudinal AP measures (4 maternal (mo) and 4 paternal (fa) at age
3, 7, 10 and 12), reflecting the stability across time and across raters.
The effect of the SNP is modeled on the AP means through the AP
factor. The arrow between the latent factors reflects the twin
correlation. The latent factors e1 to e8 denote unique factors that
account for the residual variances of the observed variables (squares).
The arrows between the unique factors reflect the twin correlations
that allow for age-dependent familial effects. The correlations differ
for MZ and DZ twin pairs. Not shown in the Figure (for the sake of
clarity), but included in the model: the variance of the AP factor,
which is constrained to 1 and the effect of sex on the means
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unique factors, and the familial correlations were equal for
boys and girls. Sex was included as covariate on the means
of the observed variables (not shown in Fig. 1).
As first step, the model was applied in the total data set to
obtain the best possible estimates for the factor loadings for
the common and unique factors and the twin correlations for
the unique factors. By using all available phenotypic data,
more reliable estimates were obtained. Secondly, the effect
of the SNPs was tested in the genotyped subsample. In this
model the factor loadings for the common and unique fac-
tors, and the twin correlations between the unique factors
were constrained at the estimates obtained in the first step
(see Table 4). The effect of the SNPs was modeled on the
AP mean through the AP latent factor (see triangle Fig. 1)
and was equal for boys and girls. The equation for AP
measured in twins at age 7 become: AP = l ? b1 *
sex ? b2 * fage7f * SNP, in which fage7f is the factor load-
ing from the AP factor on AP measured at age 7 rated by
father, b2 is the coefficient for the SNP effect on the AP
mean and b1 is the coefficient for a sex effect on the AP
mean. The SNP genotype is coded as 0, 1 or 2 reflecting the
number of minor alleles. The AP factor correlations
between twins were freely estimated, because these vary as
a function of the effect of the SNP on the latent factor.
Standard software for genetic association analyses is not
well equipped for such complex models including both
family and longitudinal data. Therefore, analyses were
performed in Mx, a software program designed for struc-
tural equation (Neale et al. 1999). To use all data, analyses
were performed on raw data using the full information
maximum likelihood (FIML) method.
For the association effect P-values below 0.05 are
reported. Because multiple testing will increase the prob-
ability of obtaining false-positive associations, a statistical
adjustment of the a-level is needed to keep the type I error
at 5%. Applying a Bonferroni correction would be too
conservative for SNPs in linkage disequilibrium (LD)
(Nyholt 2004). Therefore, the method as described by
Nyholt (2004) was applied. This method estimates the
number of independent SNPs tests for a given gene
(see: http://gump.qimr.edu.au/general/daleN/SNPSpD/). Sub-
sequently, this number (in most cases this number is less
than the number of SNPs) is used in the Bonferroni
correction. This method revealed an a-level of 0.0072,
0.018, and 0.0046 for respectively the BDNF gene, HTR2a
gene, and TPH2 gene. For the COMT gene there is only
one SNP and no correction is required.
Results
Means and factor analysis
The means and standard deviations for AP across ages and
raters are presented in Table 2. The AP means of the
genotyped sample were not different from the AP means of
the total sample of twins. For all ages, both fathers and
mothers reported more AP in boys than in girls. In the total
sample about 50% of the twin pairs had data on more than
one age. In the genotyped sample, for 86% of the twins AP
data were available for more than one age. Table 3 displays
the phenotypic stability coefficients across ages. The
stability coefficients ranged from 0.27 to 0.69 and did
not differ between girls and boys (Dv(10)
2 = 16.33,
p = 0.091). The stability was lowest between age 3 and 12,
and increases with shorter time intervals. Correlations
between paternal and maternal were between 0.60 and 0.72
and were rather similar across ages.
The factor loadings, the residual variances, and the twin
correlations for the residual variances of the model in the
total sample are given in Table 4. The AP factor explained
33, 64, 68 and 63% of the variance in maternal ratings, and
Table 2 Mean and standard deviation (SD) for AP scores at age 3, 7, 10 and 12 in the total sample and in the genotyped sample
Total sample Genotyped sample F p
Boys Girls Boys Girls
Valid N Mean SD Valid N Mean SD Valid N Mean SD Valid N Mean SD
Age 3 Mo 14331 2.9 2.2 14386 2.5 2.1 537 3.0 2.2 545 2.7 2.3 2.28 0.13
Fa 9418 2.8 2.1 9448 2.5 2.1 370 2.9 2.2 363 2.7 2.1 2.06 0.15
Age 7 Mo 8461 3.4 3.0 8645 2.5 2.8 495 3.3 2.8 519 2.5 2.7 \1 0.92
Fa 6132 3.0 2.7 6193 2.1 2.6 414 3.1 2.7 448 2.3 2.5 2.91 0.09
Age 10 Mo 5332 3.5 3.1 5698 2.4 2.9 501 3.5 2.9 505 2.7 2.8 1.09 0.30
Fa 3782 3.0 2.8 4013 2.1 2.7 410 3.1 2.7 402 2.3 2.6 1.95 0.16
Age 12 Mo 3495 3.2 3.0 3668 2.1 2.7 453 3.1 2.8 483 2.3 2.7 \1 0.64
Fa 2535 2.8 2.8 2679 1.9 2.5 371 2.7 2.7 398 1.9 2.5 \1 0.48
In the last 2 columns the statistics for the comparison of AP scores between total and genotyped sample
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34, 61, 65 and 59% in paternal ratings at ages 3, 7, 10, and
12 years. The MZ correlations for the latent AP factor was
0.82 and for 0.27 for DZ twins. A genetic twin analysis of
the AP factor revealed a broad heritability (dominance and
additive estimates) of 82%, which is slightly higher than
the heritability estimates reported for each age (ranging
from 68 to 76%) (Rietveld et al. 2003).
Association analyses
We performed the genetic association analyses in the total
sample. To be sure we did not overlook sex differences in
gene effects, we tested for sex differences by also esti-
mating SNP effects separately by sex and then constraining
the coefficient for the SNP effect to be equal for boys and
girls. No significant results were obtained for these tests
(uncorrected p-values ranged from 0.061 and 0.977). The
results of the association analyses for the whole sample are
shown in Table 1. No significant results were obtained for
any of the SNPs. The lowest p-value was found for the SNP
rs6265 (b = -0.14; p = 0.035). When we take multiple
testing into account this effect is not significant. The SNP
is known as the Val66Met polymorphism in the BDNF
gene. The ‘T’ (Met) allele was associated with a lower
score on the AP factor.
Discussion
We investigated the association between childhood AP and
SNPs in the serotonergic, dopaminergic system and the
BDNF gene. To increase the statistical power, the effect of
SNPs was tested on a latent factor that represents the sta-
bility of AP across childhood. Power calculations reported
in Middeldorp et al. (2010) showed that this method could
detect effects explaining 3% of the variance with a power
of 80%. Genetic analysis of the latent AP factor revealed a
heritability of 82%, which is slightly higher than the her-
itabilities at the separate ages. Despite the adequate sta-
tistical power, our findings do not support an influence of
any of the SNPs on AP.
The largest effect was found for the SNP rs6265
(p = 0.035). The rs6265 polymorphism is also known as
the Val66Met polymorphism and is the most reported SNP
in the BDNF gene. In the present study the Met (T) allele
carriers of the Val66MET polymorphism had decreased AP
levels. This implies that the carriers with the more common
Val allele had higher AP levels. In this respect, our results
agree with the 2 studies that reported an association
between ADHD and Val66Met with the Val allele as the
risk allele (Kent et al. 2005; Lanktree et al. 2008).
However, in literature studies with negative results
(Schimmelmann et al. 2007; Lee et al. 2007, Xu et al.
2007; Conner et al. 2008) seem to outnumber the studies
with positive results. In addition, recent meta-analyses do
not support the association between Val66Met polymor-
phism and ADHD (Sanchez-Mora et al. 2010; Forero et al.
2009). Also the results of the genome wide association
studies (GWAS) for ADHD do not indicate a role for the
Table 3 Correlations between the maternal (Mo), paternal (Fa) reports of AP at ages 3, 7, 10, and 12 years and their cross-time correlations
Age 3 Age 7 Age 10 Age 12
Girls
Boys Mo Fa Mo Fa Mo Fa Mo Fa
Age 3 Mo – 0.62 0.39 0.34 0.37 0.33 0.35 0.30
Fa 0.63 – 0.34 0.39 0.33 0.34 0.31 0.31
Age 7 Mo 0.41 0.32 – 0.67 0.64 0.55 0.57 0.49
Fa 0.35 0.37 0.72 – 0.53 0.62 0.47 0.55
Age 10 Mo 0.38 0.30 0.66 0.57 – 0.67 0.67 0.57
Fa 0.33 0.32 0.57 0.63 0.71 – 0.55 0.65
Age 12 Mo 0.34 0.27 0.61 0.53 0.72 0.62 – 0.66
Fa 0.27 0.29 0.51 0.56 0.60 0.69 0.72 –
Below diagonal: boys, above diagonal: girls
Table 4 Factor loadings for common and unique factors and the MZ
and DZ correlations (rMZ and rDZ) for the unique factors of the
model in the total sample
Age Rater Factor loading Residual SD rMZ rDZ
3 Mother 1.2337 1.7753 0.6465 0.1539
Father 1.2310 1.7186 0.6334 0.1807
7 Mother 2.3359 1.8036 0.5994 0.3254
Father 2.0936 1.7091 0.6365 0.3872
10 Mother 2.5046 1.7403 0.5652 0.3108
Father 2.2797 1.6928 0.6110 0.3767
12 Mother 2.3230 1.7810 0.6231 0.3063
Father 2.1039 1.7563 0.6472 0.4104
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BDNF gene in ADHD (Lasky-Su et al. 2008; Neale et al.
2008). In sum, the present study found a marginally sig-
nificance for the Val66Met SNP, but in the light of the
negative results in previous research the result being due to
chance cannot be ruled out.
For the dopaminergic system only the Val158Met
polymorphism of the COMT gene was available. It is the
most studied SNP for this gene and it consists of a G to A
mutation, which leads to substitution of Met for Val in
enzyme synthesis. The Val (G) allele encodes a higher
activity of COMT, which leads to a reduction of intra
synaptic dopamine (Lachman et al. 1996). In agreement
with the results of two meta analyses of COMT (Cheuk and
Wong 2006; Gizer et al. 2009), we did not find a significant
association between COMT and AP. Previous research
showed that the relation between COMT and AP is com-
plex. Some studies reported an ADHD association of the
Val allele of the COMT gene (Eisenberg et al. 1999;
Albaugh et al. 2010), while others reported a relation
between the Met allele and ADHD (Biederman et al. 2008;
DeYoung et al. 2010). In addition, the Val allele has been
associated with anti-social behaviors in children with
ADHD (Thapar et al. 2005), but not in children without
ADHD (Caspi et al. 2008). Thus, the results for COMT and
ADHD seems not to be consistent, which may be inherent
on the complexity of ADHD: A phenotype with a large
phenotypic heterogeneity, different subtypes and comor-
bidities (Banaschewski et al. 2010).
Our study included 2 genes related to the serotonergic
system (HTR2A and TPH2). For both genes we found no
association with AP problems. Quist et al. (2000) reported
a preferential transmission of the ‘T’ allele of rs6314 in
offspring with ADHD. However, other family-based asso-
ciation tests could not replicate these findings (Heiser et al.
2007; Guimaraes et al. 2007). In addition, the results of a
meta-analysis of rs6314 and ADHD were not significant
(Gizer et al. 2009). Regarding TPH2, studies have shown
inconsistent results. Some studies have shown an associa-
tion between multiple SPNs in TPH2 with ADHD (Gizer
et al. 2009; Sheehan et al. 2005; Manor et al. 2008;
Brookes et al. 2006), but others did not (Johansson et al.
2010; Sheehan et al. 2007). In addition, the direction of
association for the specific alleles was not always consis-
tent in those studies with a positive association. In con-
clusion, our data do not support a role of HTR2A and
TPH2 genes in ADHD, but for HTR2A we may not have
captured the complete genetic variability and we may have
missed the genetic variant causing the susceptibility for
AP.
The lack of positive findings could be due to including
AP measures at age 3, which show a lower correlation with
the AP measures at age 7, 10, and 12. In addition, the
Overactive scale at age 3 only shares 2 items with AP at
ages 7–12. So, it is questionable whether the two measures
have the same content. However, in a large twin study
(Rietveld et al. 2004) it was found that the overlap in
additive genetic influences across ages 3–12 was between
42 and 68% and these percentages were more or less the
same across all ages. In order to check this, we re-analyzed
the data leaving out the AP scores at age 3 and obtained the
same results.
As ADHD is more common in boys there is a discussion
whether these sex differences could be explained by dif-
ferences in genetic influences (Albayrak et al. 2008). For
example, Biederman et al. (2008) reported a significant
gender effect for the Val158Met allele of COMT, with an
effect for males, but nor for females. However, a large twin
study did not find evidence that different genes are
involved in AP for boys and girls (Rietveld et al. 2003,
2004). In addition, we tested for sex-differences of the SNP
effects, but these analyses did not reveal any sex differ-
ences in the SNP effects.
Our study has a number of limitations. The choice of the
SNPs was limited by the availability of the genotype
dataset. A shortcoming is that we could not apply the
model to genes of the dopaminergic system. Until now,
the most promising gene findings were obtained for the
dopaminergic system. Another limitation is that our study
is based on a population sample with only a few cases with
ADHD, while gene finding may be more efficient by ana-
lyzing the extreme ends of the distribution (Eaves and
Meyer 1994). This may have reduced the power. On the
other hand, by using quantitative measures we have more
information than by using dichotomized data.
A large advantage of the model is the gain in power by
using an AP measure that is obtained over time and raters.
In this way, we obtained a more reliable and persistent
phenotype of AP. In future, this model could also be useful
by analyzing the covariance of comorbid traits. In this case,
the model is used to test effects of SNPs on factors com-
mon to the traits and on factors specific for a trait (Medland
and Neale 2010). Furthermore, the model also offers an
attractive option to model longitudinal data that may be
characterized by many different patterns of missingness,
and even possibly by the use of different instruments to
assess the phenotype. As the test is carried out of at the
latent factor level, these features of the data do not need to
imply a disadvantage.
In sum, in the present study we found no evidence for an
association between AP and SNPs of the HTR2A, COMT,
TPH2 and BDNF genes. The only marginal effect was
obtained for the rs6265 SNP of the BDNF gene. Despite
the negative findings in this study, we believe that the
design is useful in genetic association studies, especially in
studies on developmental psychopathology (Middeldorp
et al. 2010).
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